Profil
Rick Kendall formerly worked at PYC Therapeutics Ltd., as Non-Executive Director in 2017, Amgen Australia Pty Ltd., as Executive Director-Oncology Research, and Kite Pharma, Inc., as Vice President-Research.
Ehemalige bekannte Positionen von Rick Kendall
| Unternehmen | Position | Ende |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 23.10.2017 |
| Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
| Amgen Australia Pty Ltd. |
